Moderna
MRNA
#290
Rank
A$119.20 B
Marketcap
A$294.61
Share price
-2.17%
Change (1 day)
685.80%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

EPS for Moderna (MRNA)

EPS in 2026 (TTM): A-$11.68

According to Moderna 's latest financial reports the company's current EPS (TTM) is A-$12.07. In 2025 the company made an earnings per share (EPS) of A-$10.98 an increase over its 2024 EPS that were of A-$14.02.

EPS history for Moderna from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$11.686.38%
2025A-$10.98-21.66%
2024A-$14.02-25.04%
2023A-$18.70-158.62%
2022A$31.91-30.25%
2021A$45.75-1660.82%
2020A-$2.9325.32%
2019A-$2.3436.87%
2018A-$1.71

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$10.09-183.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$7.93-165.71%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
A$1.50-112.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
A-$1.10-90.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
A-$3.07-74.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$29.93-347.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
A-$5.03-58.32%๐Ÿ‡บ๐Ÿ‡ธ USA